Skip to content

Reading Fluency and Accommodative Lag

Reading Fluency and Accommodative Lag

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00383175
Enrollment
72
Registered
2006-10-02
Start date
2006-08-31
Completion date
2009-10-31
Last updated
2011-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Accommodation

Keywords

Ocular Accommodation, Reading

Brief summary

The purpose of this study is to determine whether special reading glasses improve children's ability to learn to read.

Detailed description

Many children are believed to under accommodate (have a lag of accommodation) when looking at near targets. If this occurs, the retinal image is out of focus. Children who have a lag of accommodation may have difficulty in focusing their eyes at near for long periods of time. This difficulty could reduce their ability to read fluently. Children with above average lags of accommodation will be randomly assigned to a group which receives special reading glasses or a group which does not. The groups will be assessed using a standard test for reading fluency.

Interventions

OTHERAutorefractor, standard clinical instrument

Autorefractor, standard clinical instrument was used to assess the children's focusing power at near.

Sponsors

National Eye Institute (NEI)
CollaboratorNIH
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Children in grades 1, 2 and 3 who consent and assent to participate

Exclusion criteria

* Children in the special education program * Children who are unwilling to have their eyes dilated or be tested * Children who are unwilling to wear the glasses

Design outcomes

Primary

MeasureTime frame
DIBELS test scores .1 -2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026